Clinical Trial: A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836504) titled 'A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.' on Sept. 11.

Brief Summary: This is a two-part single-center, open-label, parallel, single-dose pharmacokinetic study of HS-10504 in participants with hepatic impairment and normal hepatic function.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: To Compare the Pharmacokinetic (PK) Differences of HS-10504 Between Participants With Hepatic Impairment and Participants With Normal Hepatic Function

Intervention: DRUG: HS-10504

HS-10504:On Day 1, a single oral dose of 400 mg HS-10504 tablet was administered i...